Bausch Health Companies Inc.

BHC

NYSE

6.13

USD

-0.15(-2.39%)

As of today

Overview Financials Dividends Ratios Discussions Analysis

Bausch Health Companies Inc. fundamentals

Overview Income Statement Balance Sheet Cash Flow

Key ratios

P/E Ratio

6.32

Price/Book

-4.02

Debt/Equity

-3720.62%

Return on Equity

-38.20%

Dividend Yield

0.00%

EBITDA

3.13B

Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, Ortho Dermatologics, and Diversified Products. The Bausch + Lomb segment offers products with a focus on the vision care, surgical, and consumer, surgical, and ophthalmic pharmaceuticals products. The Salix segment provides gastroenterology products in the United States. The International Rx segment offers Solta products, branded and generic pharmaceutical products, OTC products, and medical device products, and Bausch + Lomb products in Canada, Europe, Asia, Australia, Latin America, Africa, and the Middle East. The Ortho Dermatologics segment provides dermatological products in the United States; and Solta medical aesthetic devices internationally. The Diversified Products segment offers pharmaceutical products in the areas of neurology and other therapeutic classes, as well as generic and dentistry products in the United States. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.

Statements Highlights

AnnualQuarterly

Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024
Total Revenue	8,027,000,000	8,434,000,000	8,124,000,000	8,757,000,000	9,625,000,000
Gross Profit	5,778,000,000	6,040,000,000	5,760,000,000	6,198,000,000	6,843,000,000
Operating Income	676,000,000	450,000,000	454,000,000	963,000,000	1,546,000,000
Net Income	-559,000,000	-948,000,000	-225,000,000	-592,000,000	-46,000,000
Total Assets	31,199,000,000	29,202,000,000	25,686,000,000	27,350,000,000	26,523,000,000
Total Current Liabilities	4,913,000,000	5,198,000,000	3,941,000,000	4,302,000,000	6,752,000,000
Total Equity	605,000,000	-34,000,000	260,000,000	-82,000,000	-322,000,000
Free Cash Flow	802,000,000	1,143,000,000	-996,000,000	760,000,000	1,260,000,000
Cash from Operations	1,111,000,000	1,426,000,000	-728,000,000	1,032,000,000	1,597,000,000
Cash from Investing	-261,000,000	409,000,000	-303,000,000	-2,145,000,000	-454,000,000
Cash from Financing	-2,294,000,000	-1,513,000,000	-474,000,000	1,475,000,000	-868,000,000
Net Change in Cash	-1,428,000,000	303,000,000	-1,528,000,000	371,000,000	239,000,000

Bausch Health Companies Inc.

BHC

6.13

Bausch Health Companies Inc. fundamentals

Key ratios

Statements Highlights

Analyst Recomendations